355 related articles for article (PubMed ID: 32235004)
41. Construction of a Colorectal Cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms.
Du X; Qi H; Ji W; Li P; Hua R; Hu W; Qi F
Comput Math Methods Med; 2022; 2022():9408839. PubMed ID: 36267311
[TBL] [Abstract][Full Text] [Related]
42. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
[TBL] [Abstract][Full Text] [Related]
43. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer.
Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W
Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182
[TBL] [Abstract][Full Text] [Related]
44.
Li N; Xiao H; Shen J; Qiao X; Zhang F; Zhang W; Gao Y; Liu YD
J Int Med Res; 2021 Apr; 49(4):3000605211004386. PubMed ID: 33845603
[TBL] [Abstract][Full Text] [Related]
45. Development of an immune-related gene prognostic risk model and identification of an immune infiltration signature in the tumor microenvironment of colon cancer.
Hao M; Li H; Yi M; Zhu Y; Wang K; Liu Y; Liang X; Ding L
BMC Gastroenterol; 2023 Mar; 23(1):58. PubMed ID: 36890467
[TBL] [Abstract][Full Text] [Related]
46. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
[TBL] [Abstract][Full Text] [Related]
47. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
48. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
49. Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis.
Xu N; Ke ZB; Lin XD; Chen YH; Wu YP; Chen Y; Dong RN; Chen SH; Li XD; Wei Y; Zheng QS; Lin YZ; Xue XY
Cancer Cell Int; 2020; 20():302. PubMed ID: 32675942
[TBL] [Abstract][Full Text] [Related]
50. Expression Profile Analysis Identifies a Novel Seven Immune-Related Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Hu L; Han Z; Cheng X; Wang S; Feng Y; Lin Z
Front Genet; 2021; 12():638458. PubMed ID: 33708242
[TBL] [Abstract][Full Text] [Related]
51. Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.
Jin Y; Deng J; Luo B; Zhong Y; Yu S
Front Endocrinol (Lausanne); 2022; 13():963382. PubMed ID: 36440228
[TBL] [Abstract][Full Text] [Related]
52. Development of a prognostic signature for esophageal cancer based on nine immune related genes.
Zhang Z; Chen C; Fang Y; Li S; Wang X; Sun L; Zhou G; Ye J
BMC Cancer; 2021 Feb; 21(1):113. PubMed ID: 33541291
[TBL] [Abstract][Full Text] [Related]
53. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Chen Y; Yu X; Xu Y; Shen H
Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
[TBL] [Abstract][Full Text] [Related]
54. Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis.
Zhang J; Zhang J; Yuan C; Luo Y; Li Y; Dai P; Sun W; Zhang N; Ren J; Zhang J; Gong Y; Xie C
Cancer Cell Int; 2020; 20():330. PubMed ID: 32699529
[TBL] [Abstract][Full Text] [Related]
55. A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
Tang Y; Hu Y; Wang J; Zeng Z
Int Immunopharmacol; 2020 Oct; 87():106851. PubMed ID: 32763782
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
57. A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer.
Hong J; Lin X; Hu X; Wu X; Fang W
Curr Gene Ther; 2021; 21(4):280-289. PubMed ID: 33045967
[TBL] [Abstract][Full Text] [Related]
58. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
59. Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
Fu B; Du C; Wu Z; Li M; Zhao Y; Liu X; Wu H; Wei M
Aging (Albany NY); 2020 Nov; 12(22):22814-22839. PubMed ID: 33203797
[TBL] [Abstract][Full Text] [Related]
60. Bioinformatic analysis of RNA-seq data from TCGA database reveals prognostic significance of immune-related genes in colon cancer.
Ouyang Y; Huang J; Wang Y; Tang F; Hu Z; Zeng Z; Zhang S
Medicine (Baltimore); 2022 Aug; 101(31):e29962. PubMed ID: 35945793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]